Pharma fever grips dealmakers despite M&A spike and a frenzy IPO year, Health News, ET HealthWorld
Several high-profile investment bankers opted to stay out of the dealmaking business to join more strategic roles in the last 12-18 months, despite record M&A volumes and a frenzy IPO…

